view article

Figure 2
Low-resolution (3.1 Å) apoferritin maps. (a) Original 3.1 Å resolution apoferritin map, half-map sharpened (Terwilliger et al., 2018BB46). (b) Map obtained using density modification but no model-based information. (c) Map obtained using an automatically generated ensemble model. The model shown is from the crystallographic structure of human apoferritin (Masuda et al., 2010BB19), re-refined against the 1.8 Å resolution apoferritin map (EMDB EMD-20026). Arrows indicate locations in the map where the clarity is improved by density modification. (d) Fourier shell correlation of the maps shown in (a) (blue; labeled initial map), (b) (orange; labeled density modified) and (c) (black; labeled density modified with models) with the high-resolution (1.8 Å) apoferritin map (EMDB EMD-20026). The density-modification analysis was carried out to a resolution of 2 Å so all Fourier terms from the density-modified map are zero beyond this resolution and therefore all FSC values are zero as well.

Journal logoSTRUCTURAL
BIOLOGY
ISSN: 2059-7983
Follow Acta Cryst. D
Sign up for e-alerts
Follow Acta Cryst. on Twitter
Follow us on facebook
Sign up for RSS feeds